Johnson & Johnson (JNJ) Akcija Цена

Johnson & Johnson Цена

NYSE·ZATVORENO
268,48
​
Tržište je zatvoreno

U poslednjih 19 godina prihod Johnson & Johnson rastao je 3,0 % godišnje i dostigao 94,19 Млрд USD. Zarada po akciji rasla je 5,8 % godišnje u poslednjih 19 godina. Za Johnson & Johnson neto marža od 28,5 % je porasla u odnosu na 26,5 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 1,91 %. Odnos isplate je oko 47 % dobiti. Dividenda je rasla 6,9 % godišnje u poslednjih 19 godina. Konsenzusna 12-mesečna ciljana cena za Johnson & Johnson je 282,00 USD, oko iznad kurs za 5,0 %. Od 30 analitičara 21 preporučuje kupovinu — ukupni konsenzus je Kupi.

Cena akcije Johnson & Johnson

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Johnson & Johnson poslovni model i analiza akcije

Johnson & Johnson je američka kompanija osnovana 1886. godine od strane braće Roberta, Džejmsa i Edvarda Džonsona. Kompanija ima sedište u Nju Brunsviku, u državi Nju Džerzi, SAD, i danas posluje na međunarodnom nivou sa više od 130.000 zaposlenih širom sveta. Istorija kompanije Johnson & Johnson počinje proizvodnjom medicinskih zavoja. Godine 1887. izumljen je i patentiran prvi samolepljivi flaster za rane. U narednim godinama asortiman proizvoda je značajno proširen i danas obuhvata širok spektar zdravstvenih proizvoda. To uključuje farmaceutske preparate, medicinske uređaje, higijenske proizvode, proizvode za ličnu negu i proizvode za bebe. Poslovni model kompanije Johnson & Johnson usmeren je na poboljšanje kvaliteta života ljudi širom sveta. Kompanija pridaje veliki značaj inovacijama, kvalitetu i održivosti. Sa dugogodišnjim iskustvom i stručnošću u zdravstvenoj industriji, Johnson & Johnson je u stanju da razume potrebe kupaca i ponudi proizvode prilagođene njihovim specifičnim potrebama. Johnson & Johnson trenutno deluje u tri glavna poslovna segmenta: Potrošačko zdravlje (Consumer Health), Medicinski uređaji i dijagnostika, i Farmaceutski proizvodi. Unutar ovih poslovnih segmenata postoji mnogo brendova i proizvoda koji su među najpoznatijima na svetu. Segment potrošačkog zdravlja kompanije Johnson & Johnson fokusiran je na proizvodnju zdravstvenih proizvoda i proizvoda za ličnu negu za potrošače. Neki od poznatih brendova u ovom području uključuju Listerine, Johnson's Baby, Neutrogena i Nicorette. Kompanija nudi širok spektar proizvoda, od lekova za prehladu i alergije do proizvoda za negu kože i pasta za zube. Medicinski uređaji i dijagnostika još su jedan ključni poslovni segment kompanije Johnson & Johnson. Kompanija je vodeći svetski pružalac medicinskih uređaja i dijagnostičkih proizvoda. Proizvodi u ovom području uključuju hirurške sisteme, implantabilne uređaje, dijagnostičke testove i uređaje za slikovnu dijagnostiku. Poznati brendovi u ovom segmentu uključuju Ethicon, Depuy Synthes i Cordis. Farmaceutski proizvodi predstavljaju treći glavni poslovni segment kompanije Johnson & Johnson. Kompanija razvija i proizvodi inovativne farmaceutske preparate za lečenje bolesti poput raka, dijabetesa, srčanih oboljenja i neuroloških poremećaja. Neki od poznatih brendova u ovom području uključuju Remicade, Invega i Zytiga. Johnson & Johnson je takođe poznat po svojoj posvećenosti održivosti i korporativnoj društvenoj odgovornosti. Kompanija je posvećena tome da ostvari pozitivan uticaj na životnu sredinu i zajednice u kojima posluje. Na primer, Johnson & Johnson teži smanjenju emisije CO2 za 60% do 2030. godine. U celini, Johnson & Johnson je vodeća kompanija u zdravstvenoj industriji koja se fokusira na pružanje inovativnih i visokokvalitetnih proizvoda koji poboljšavaju život ljudi širom sveta. Sa širokim spektrom brendova i proizvoda u različitim poslovnim segmentima, kompanija je dobro pozicionirana da nastavi sa uspehom u budućnosti.

Često postavljana pitanja o akciji Johnson & Johnson

Johnson & Johnson operates under a diversified business model. The company is engaged in the development, manufacturing, and marketing of a wide range of healthcare products. Their business segments include pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for their innovative approach in creating advanced treatments and solutions for various health conditions and diseases. With a focus on research and development, they strive to provide high-quality products that improve the well-being of people around the world. Johnson & Johnson's commitment to delivering value to their customers and stakeholders drives their success in the global healthcare industry.

Johnson & Johnson is primarily active in the healthcare industry. With a diverse range of products, the company operates in multiple sectors such as pharmaceuticals, medical devices, and consumer health. Johnson & Johnson is renowned for its comprehensive portfolio that includes prescription drugs, over-the-counter medications, surgical equipment, contact lenses, and personal care products. Being a global leader, Johnson & Johnson's presence extends across various healthcare segments, enabling it to contribute significantly to advancing medical solutions and enhancing overall well-being.

Some of the main competitors of Johnson & Johnson in the market include Pfizer Inc., Merck & Co., Inc., and Roche Holding AG.

Johnson & Johnson is a multinational healthcare company that was founded in 1886. It has a rich history and has become a leader in the pharmaceutical, medical devices, and consumer healthcare sectors. With over 130 years of experience, Johnson & Johnson has continually focused on delivering innovative solutions to improve the health and well-being of people around the world. The company has grown through strategic acquisitions and partnerships, expanding its product portfolio and global presence. Johnson & Johnson's commitment to research and development, along with its dedication to ethical business practices, have made it a trusted name in the healthcare industry.

Some significant milestones achieved by Johnson & Johnson include the development of innovative medical treatments and breakthrough pharmaceutical products. Throughout its history, the company has also played a crucial role in the advancement of healthcare technology and the improvement of patient care. Johnson & Johnson has consistently demonstrated its commitment to quality and safety, earning a reputation as a trusted global healthcare leader. With a strong focus on research and development, the company has introduced numerous life-saving and life-enhancing solutions to address a wide range of medical needs. Through its dedication to innovation and excellence, Johnson & Johnson continues to shape the future of healthcare.

Johnson & Johnson is primarily present in several countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered, and it operates in countries across North America, Europe, Asia Pacific, and Latin America. Some prominent regions where Johnson & Johnson operates include Canada, Germany, France, Japan, Australia, Brazil, and China. With its diverse portfolio of healthcare products and services, Johnson & Johnson continues to expand its presence globally, serving the healthcare needs of people in numerous countries and regions.

Johnson & Johnson is a renowned global healthcare company that upholds strong values and a clear corporate philosophy. With a commitment to improving the well-being of people worldwide, the company focuses on three fundamental principles: caring for the world, keeping customers at the center, and cherishing employees. Johnson & Johnson values integrity, innovation, diversity, and collaboration, consistently striving to deliver high-quality products and solutions. With a customer-centric approach, the company endeavors to create lasting relationships and enhance experiences. By fostering a supportive work environment and promoting professional growth, Johnson & Johnson ensures its employees play a vital role in achieving its mission.

Analitičari trenutno postavljaju prosečnu ciljanu cenu 282,08 USD za akciju Johnson & Johnson (medijana: 282,00 USD), što znači +4,8 % u odnosu na poslednju cenu. Konsenzus se zasniva na 30 ocena.

30 analitičara trenutno ocenjuje akciju Johnson & Johnson: 21 preporučuje kupovinu, 9 držanje i 0 prodaju. Za 2026 analitičari očekuju da Johnson & Johnson ostvari prihod 101,21 Млрд USD i zaradu po akciji 11,07 USD.

Po trenutnom kursu akcija Johnson & Johnson kotira 239,83 EUR (268,48 USD).

Akcija Johnson & Johnson (JNJ) kotira na 12 berze, uključujući: NYSE (JNJ), London (0R34.L), SIX (Zürich) (JNJUSD.SW), XETRA (JNJ.DE), Frankfurt (JNJ.F), München (JNJ.MU), Stuttgart (JNJ.SG), Düsseldorf (JNJ.DU).

Johnson & Johnson is one of the largest healthcare companies in the world. The company was founded in 1886 and is based in New Brunswick, New Jersey. With a wide portfolio of products and services, Johnson & Johnson is active in the consumer goods, medical technology, and pharmaceutical sectors. Consumer Goods: Johnson & Johnson is best known for its baby care products, such as diapers and wipes. The company also offers a wide range of other products, including personal care, wound healing, and pain relief products. Medical Technology: As a global leader in medical devices and instruments, Johnson & Johnson provides solutions for various areas of the medical field. In orthopedics, for example, the company offers implants for a variety of joints and bones. In medical imaging, Johnson & Johnson has a diverse range of devices that can be used for diagnosis and treatment. Pharmaceuticals: Johnson & Johnson is also active in the pharmaceutical business. The company is a global leader in the development and marketing of prescription drugs. In the field of oncology, for example, Johnson & Johnson offers various medications for the treatment of cancer. The company is also involved in neurology and immunology, offering a wide range of medications. Innovative Technologies: Johnson & Johnson heavily invests in innovative technologies to improve treatment options for patients. Examples of this include the "CaringCrowd" crowdfunding platform and the "Janssen Health EMEA Innovation Center," a platform for start-ups and companies focusing on groundbreaking innovations in healthcare. Research and Development: Research and development is a crucial aspect of Johnson & Johnson's business success. The company invests significant amounts each year in the research and development of new products and technologies. The goal is to develop products that meet the needs of patients and address various diseases and conditions. Johnson & Johnson also conducts extensive clinical studies to ensure the safety and efficacy of its products. Conclusion: Johnson & Johnson has a diverse range of products and services. The company is a leading provider in consumer goods, medical technology, and pharmaceuticals. It heavily invests in innovative technologies and research and development to offer treatment options to patients worldwide that meet the highest standards in terms of efficacy and safety. The output answer: Johnson & Johnson is a global healthcare company that offers a wide range of consumer goods, medical technology, and pharmaceutical products. It invests in innovative technologies and research and development to provide effective and safe treatment options for patients worldwide.

očekivana prihod od Johnson & Johnson je 101,21 Млрд USD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.

očekivana dobit od Johnson & Johnson je 26,99 Млрд USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.

Odnos cene i zarade (KGV) za Johnson & Johnson je trenutno 24,26. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Johnson & Johnson.

Odnos cene i prihoda (KUV) za Johnson & Johnson je trenutno 6,47. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Johnson & Johnson.

Eulpool score kvaliteta za Johnson & Johnson je 7/10.

ISIN za Johnson & Johnson je US4781601046. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za Johnson & Johnson je 853260. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za Johnson & Johnson je JNJ. Simbol tikera se koristi za trgovinu akcijama Johnson & Johnson na berzanskom tržištu.

Фер вредностTerminal
268,48 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Фармацеутски производи
Број акција
Запослени
Приход по запосленом
681.570,19 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт jnj.com
Валута
USD
Јавна понуда
25. сеп 1944.
ISIN
US4781601046
SEDOL
2475833
Тржишна капитализација
Опсег од 52 недеље
AAQS
7 / 10
PEG
2,50
P/E однос
P/Ee 2026
24,17
P/Ee 2027
23,15
P/Ee 2028
19,22
P/Ee 2029
17,08
P/Ee 2030
15,17
P/S
P/Se
6,47
EV/EBIT
26,59
P/B однос
8,00
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
20,70 %
Дивиденда
Прinos од дивиденде
1,91 %
Процењени принос од дивиденде
1,98 %
Стопа исплате
46,77 %
Раст дивиденде Ø5Y
4,17 %
Дивиденде по години
4
Дивиденда исплаћена од
36 година
Дивиденда није смањена од
36 година
Дивиденда повећана од
36 година
Порез на дивиденде
30,00 %
Zadnje ažurirano 3. нов 2026. 19:33

Johnson & Johnson Тикер

BERLIN · JNJ.BEDISELORF · JNJ.DUFRANKFURT · JNJ.FHAMBURG · JNJ.HMLONDON · 0R34.LMILAN · 1JNJ.MIMINHEN · JNJ.MUNEW YORK · JNJSIX · JNJUSD.SWŠTUTGART · JNJ.SGBEČ · JNJ.VIXETRA · JNJ.DE

Johnson & Johnson FIGI

JNJ:US · BBG000BMHYD1JNJ:UA · BBG000BMHYP8JNJ:UC · BBG000BMHYZ7JNJ:UN · BBG000BMHZY5JNJ:UP · BBG000BMJ0L4JNJ:UB · BBG000BMJ1J5JNJ:UT · BBG000BMJ230JNJ:UM · BBG000BMJ2D9JNJ:UX · BBG000BMJ329JNJ:UD · BBG000BMJ4Y2JNJ:UF · BBG000BMJ720JNJ:VY · BBG000BMJ7H4